VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 452 filers reported holding VANECK VECTORS ETF TR in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,081,000 | +58.1% | 111,254 | -0.7% | 0.67% | +39.1% |
| Q1 2020 | $2,582,000 | -40.6% | 112,065 | -24.5% | 0.48% | -31.1% |
| Q4 2019 | $4,345,000 | +35.6% | 148,390 | +23.7% | 0.70% | +5.8% |
| Q3 2019 | $3,205,000 | +4.5% | 119,980 | -0.0% | 0.66% | -4.8% |
| Q2 2019 | $3,067,000 | -26.2% | 119,981 | -36.6% | 0.69% | -33.6% |
| Q1 2019 | $4,157,000 | +40.8% | 189,130 | +35.1% | 1.04% | +16.0% |
| Q4 2018 | $2,952,000 | -15.2% | 139,981 | -25.6% | 0.90% | -9.9% |
| Q3 2018 | $3,483,000 | -17.4% | 188,076 | -0.6% | 1.00% | -20.5% |
| Q2 2018 | $4,219,000 | +1.5% | 189,130 | 0.0% | 1.26% | +21.2% |
| Q1 2018 | $4,157,000 | -5.4% | 189,130 | 0.0% | 1.04% | -5.2% |
| Q4 2017 | $4,395,000 | +1.2% | 189,130 | 0.0% | 1.09% | -2.1% |
| Q3 2017 | $4,342,000 | – | 189,130 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |